Laquinimod Treatment Improves Myelination Deficits at the Transcriptional and Ultrastructural Levels in the YAC128 Mouse Model of Huntington Disease

2018 ◽  
Vol 56 (6) ◽  
pp. 4464-4478 ◽  
Author(s):  
Marta Garcia-Miralles ◽  
Nur Amirah Binte Mohammad Yusof ◽  
Jing Ying Tan ◽  
Carola I. Radulescu ◽  
Harwin Sidik ◽  
...  
Keyword(s):  
Mouse Model ◽  
Huntington Disease ◽  
Yac128 Mouse

scholarly journals Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease

2005 ◽  
Vol 95 (1) ◽  
pp. 210-220 ◽  
Author(s):  
Jeremy M. Van Raamsdonk ◽  
Jacqueline Pearson ◽  
Craig D. C. Bailey ◽  
Daniel A. Rogers ◽  
Gail V. W. Johnson ◽  
...  
Keyword(s):  
Mouse Model ◽  
Huntington Disease ◽  
Yac128 Mouse

scholarly journals Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease

2005 ◽  
Vol 14 (24) ◽  
pp. 3823-3835 ◽  
Author(s):  
Jeremy M. Van Raamsdonk ◽  
Zoe Murphy ◽  
Elizabeth J. Slow ◽  
Blair R. Leavitt ◽  
Michael R. Hayden
Keyword(s):  
Mouse Model ◽  
Nuclear Localization ◽  
Huntington Disease ◽  
Mutant Huntingtin ◽  
Yac128 Mouse

scholarly journals DAPK1 Promotes Extrasynaptic GluN2B Phosphorylation and Striatal Spine Instability in the YAC128 Mouse Model of Huntington Disease

2020 ◽  
Vol 14 ◽  
Author(s):  
Mandi E. Schmidt ◽  
Nicholas S. Caron ◽  
Amirah E. Aly ◽  
Fanny L. Lemarié ◽  
Louisa Dal Cengio ◽  
...  
Keyword(s):  
Mouse Model ◽  
Huntington Disease ◽  
Yac128 Mouse

scholarly journals Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease

2005 ◽  
Vol 14 (10) ◽  
pp. 1379-1392 ◽  
Author(s):  
Jeremy M. Van Raamsdonk ◽  
Jacqueline Pearson ◽  
Daniel A. Rogers ◽  
Nagat Bissada ◽  
A. Wayne Vogl ◽  
...  
Keyword(s):  
Mouse Model ◽  
Huntington Disease ◽  
Motor Dysfunction ◽  
Wild Type ◽  
Yac128 Mouse

Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain

2007 ◽  
Vol 26 (1) ◽  
pp. 189-200 ◽  
Author(s):  
Jeremy M. Van Raamsdonk ◽  
Martina Metzler ◽  
Elizabeth Slow ◽  
Jacqueline Pearson ◽  
Claudia Schwab ◽  
...  
Keyword(s):  
Mouse Model ◽  
Huntington Disease ◽  
Yac128 Mouse

NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease

2012 ◽  
Vol 48 (3) ◽  
pp. 282-289 ◽  
Author(s):  
Mahmoud A. Pouladi ◽  
Elsa Brillaud ◽  
Yuanyun Xie ◽  
Paola Conforti ◽  
Rona K. Graham ◽  
...  
Keyword(s):  
Mouse Model ◽  
Huntington Disease ◽  
Low Dose ◽  
Yac128 Mouse

Ethyl-EPA treatment improves motor dysfunction, but not neurodegeneration in the YAC128 mouse model of Huntington disease

2005 ◽  
Vol 196 (2) ◽  
pp. 266-272 ◽  
Author(s):  
Jeremy M. Van Raamsdonk ◽  
Jacqueline Pearson ◽  
Daniel A. Rogers ◽  
Ge Lu ◽  
Vilte E. Barakauskas ◽  
...  
Keyword(s):  
Mouse Model ◽  
Huntington Disease ◽  
Motor Dysfunction ◽  
Yac128 Mouse

scholarly journals Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease

2009 ◽  
Vol 29 (8) ◽  
pp. 2414-2427 ◽  
Author(s):  
P. R. Joshi ◽  
N.-P. Wu ◽  
V. M. Andre ◽  
D. M. Cummings ◽  
C. Cepeda ◽  
...  
Keyword(s):  
Mouse Model ◽  
Huntington Disease ◽  
Age Dependent ◽  
Yac128 Mouse

scholarly journals Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin

Brain ◽  
2008 ◽  
Vol 132 (4) ◽  
pp. 919-932 ◽  
Author(s):  
M. A. Pouladi ◽  
R. K. Graham ◽  
J. M. Karasinska ◽  
Y. Xie ◽  
R. D. Santos ◽  
...  
Keyword(s):  
Mouse Model ◽  
Huntington Disease ◽  
Yac128 Mouse
Sign in / Sign up

Export Citation Format

Share Document